Amgen Engages Cambridge Biotech Community To Select 2018 LabCentral Golden Ticket Winners

Amgen Golden Tickets Provide Startup Companies With Free Lab Space to Further Advance Innovative Science and Technology CAMBRIDGE, Mass., Dec. 18, 2018 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and LabCentral today announced that Kernal Biologics and PanTher Therapeutics have each won the Amgen Golden Ticket at LabCentral. The two Golden Ticket winners were chosen by an Amgen internal committee and live audience members at a "Quick Pitch" event hosted by Amgen at its Cambridge, Mass. facility on Dec. 11, 2018. Six finalists pitched their business plans to attendees where the audience members' votes served as input for the Amgen internal committee's decision. As a LabCentral platinum sponsor...
Source: Amgen News Release - Category: Pharmaceuticals Tags: Uncategorized Source Type: news